The DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.
Formation of Isoprostane-like Compounds (Neuroprostanes) in Vivo from Docosahexaenoic Acid
Open accessAbstract
F2-isoprostanes are prostaglandin F2-like compounds that are formed nonenzymatically by free radical-induced oxidation of arachidonic acid. We explored whether oxidation of docosahexaenoic acid (C22:6omega3), which is highly enriched in the brain, led to the formation of F2-isoprostane-like compounds, which we term F4-neuroprostanes. Oxidation of docosahexaenoic acid in vitro yielded a series of compounds that were structurally established to be F4-neuroprostanes using a number of mass spectrometric approaches. The amounts formed exceeded levels of F2-isoprostanes generated from arachidonic acid by 3.4-fold. F4-neuroprostanes were detected esterified in normal whole rat brain and newborn pig cortex at a level of 7.0 +/- 1.4 ng/g and 13.1 +/- 8 ng/g, respectively. Furthermore, F4-neuroprostanes could be detected in normal human cerebrospinal fluid and levels in patients with Alzheimer's disease (110 +/- 12 pg/ml) were significantly higher than age-matched controls (64 +/- 8 pg/ml) (p < 0.05). F4-neuroprostanes may provide a unique marker of oxidative injury to the brain and could potentially exert biological activity. Furthermore, the formation of F4-neuroprostane-containing aminophospholipids might adversely effect neuronal function as a result of alterations they induce in the biophysical properties of neuronal membranes.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Mirra, S. S., Heyman, A., McKeel, D., Sumi, S. M., Crain, B. J., Brownlee, L. M., Vogel, F. S., Hughes, J. P., Belle, G. V., Berg, L., et al. (1991) · Neurology · doi:10.1212/wnl.41.4.479 · Cited by 4,961
Diagnosis of Alzheimer's Disease
Khachaturian, Z. S. (1985) · Archives of Neurology · doi:10.1001/archneur.1985.04060100083029 · Cited by 2,499
Oxidative Stress in Neurodegenerative Diseases
Simonian, N. A., & Coyle, J. T. (1996) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pa.36.040196.000503 · Cited by 1,377
Research works printed but not linked: 21
- Morrow, 1990, Proc. Natl. Acad. Sci. U. S. A., 87, 9383, 10.1073/pnas.87.23.9383 · DOI · Paper page
- Morrow, 1994, J. Biol. Chem., 269, 4317, 10.1016/S0021-9258(17)41781-9 · DOI · Paper page
- Morrow, 1996, J. Biol. Chem., 271, 23185, 10.1074/jbc.271.38.23185 · DOI
- Morrow, 1992, Proc. Natl. Acad. Sci. U. S. A., 89, 10721, 10.1073/pnas.89.22.10721 · DOI · Paper page
- Roberts, 1997, Biochim. Biophys. Acta, 1345, 121, 10.1016/S0005-2760(96)00162-2 · DOI · Paper page
- Morrow, 1997, Prog. Lipid Res., 36, 1, 10.1016/S0163-7827(97)00001-5 · DOI · Paper page
- Skinner, 1993, Brain, 116, 717, 10.1093/brain/116.3.717 · DOI
- Moore, 1991, J. Neurochem., 56, 518, 10.1111/j.1471-4159.1991.tb08180.x · DOI · Paper page
- Conner, 1992, Nutr. Rev., 50, 21, 10.1111/j.1753-4887.1992.tb01286.x · DOI · Paper page
- Knight, 1997, Ann. Clin. Lab. Sci., 27, 11
- Markesbery, 1997, Free Radic. Biol. Med., 23, 134, 10.1016/S0891-5849(96)00629-6 · DOI · Paper page
- Salem, 1995, Mol. Membr. Biol., 12, 131, 10.3109/09687689509038508 · DOI
- Taber, 1997, Prostaglandins, 53, 63, 10.1016/S0090-6980(97)00005-1 · DOI · Paper page
- Longmire, 1994, Biochem. Pharmacol., 47, 1173, 10.1016/0006-2952(94)90389-1 · DOI
- Morrow, 1994, Methods Enzymol., 233, 163, 10.1016/S0076-6879(94)33019-0 · DOI · Paper page
- Morrow, 1990, Anal. Biochem., 184, 1, 10.1016/0003-2697(90)90002-Q · DOI · Paper page
- Pace-Acsiak, 1971, J. Chromatogr., 56, 129, 10.1016/S0021-9673(00)97786-0 · DOI
- Pace-Asciak, 1989, Adv. Prostaglandin Thromboxane Leukotriene Res., 18, 322
- Lovell, 1997, Neurobiol. Aging, 18, 457, 10.1016/S0197-4580(97)00108-5 · DOI · Paper page
- Montine, 1997, Am. J. Pathol., 151, 1571
- Bourre, 1984, J. Neurochem., 43, 342, 10.1111/j.1471-4159.1984.tb00906.x · DOI · Paper page
Cited by
Oxidative stress and mitochondrial dysfunction in Alzheimer’s disease
Wang, X., Wang, W., Li, L., Perry, G., Lee, H.-G., & Zhu, X. (2014) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2013.10.015 · Cited by 1,357
Evidence of oxidative damage in Alzheimer's disease brain: central role for amyloid β-peptide
Butterfield, D. A., Drake, J., Pocernich, C., & Castegna, A. (2001) · Trends in Molecular Medicine · doi:10.1016/s1471-4914(01)02173-6 · Cited by 1,114
Reactive oxygen species, cell signaling, and cell injury
Hensley, K., Robinson, K. A., Gabbita, S. P., Salsman, S., & Floyd, R. A. (2000) · Free Radical Biology and Medicine · doi:10.1016/s0891-5849(00)00252-5 · Cited by 1,019
Oxidative stress in brain agingImplications for therapeutics of neurodegenerative diseases
FLOYD, R., & HENSLEY, K. (2002) · Neurobiology of Aging · doi:10.1016/s0197-4580(02)00019-2 · Cited by 830
Marcheselli, V. L., Hong, S., Lukiw, W. J., Tian, X. H., Gronert, K., Musto, A., Hardy, M., Gimenez, J. M., Chiang, N., Serhan, C. N., et al. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m305841200 · Cited by 802
Metadata
- Authors
- Roberts, L. J., Montine, T. J., Markesbery, W. R., Tapper, A. R., Hardy, P., Chemtob, S., Dettbarn, W. D., & Morrow, J. D.
- Venue
- Journal of Biological Chemistry
- Publisher
- Elsevier BV
- Published
- 1998-05
- Volume
- 273
- Issue
- 22
- Pages
- 13605-13612
- ISSN
- 0021-9258 (ISSN-L)
- OpenAlex
- W2109439103
- Cited by
- 418
- References
- 3
- FWCI
- 18.98
- Type
- journal article
- Language
- en
- Open access
- hybrid
- Licence
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- creativecommons.org/licenses/by/4.0/ (vor, 8188 d)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Formation of Isoprostane-like Compounds (Neuroprostanes) in Vivo from Docosahexaenoic Acid. https://app.cochat.ai/papers/10.1074/jbc.273.22.13605
- The paper
- Roberts, L. J., Montine, T. J., Markesbery, W. R., Tapper, A. R., Hardy, P., Chemtob, S., Dettbarn, W. D., & Morrow, J. D. (1998). Formation of Isoprostane-like Compounds (Neuroprostanes) in Vivo from Docosahexaenoic Acid. Journal of Biological Chemistry. https://doi.org/10.1074/jbc.273.22.13605
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.